The triatomine vectors of Chagas disease are obligate haematophagous insect
s, feeding on vertebrate blood throughout their entire developmental cycle.
As a result of obtaining their nutrition from a single food source, their
diet is devoid of certain vitamins and nutrients. Consequently, these insec
ts harbour populations of bacterial symbionts within their intestinal tract
, which provide the required nutrients that are lacking from their diet. We
have isolated and characterised symbiont cultures from various triatomine
species and developed a method for genetically transforming them. We can th
en reintroduce them into their original host species, thereby producing sta
ble paratransgenic insects in which we are able to express heterologous gen
e products. Using this methodology, we have generated paratransgenic Rhodni
us prolixus that are refractory for infection with Trypanosoma cruzi. Two e
xamples of potentially refractory genes are currently being expressed in pa
ratransgenic insects. These include the insect immune peptide cecropin A an
d active single chain antibody fragments. We have also developed an approac
h that would allow introduction of genetically modified bacterial symbionts
into natural populations of Chagas disease vectors. This approach utilises
the coprophagic behaviour of these insects, which is the way in which the
symbionts are transmitted among bug populations in nature. The production a
nd ultimate release of transgenic or paratransgenic insects for public heal
th applications is potentially very promising but also worthy of much caref
ul consideration with respect to environmental, political, and human safety
concerns. (C) 2001 Australian Society for Parasitology Inc. Published by E
lsevier Science Ltd. All rights reserved.